One Stop Shop for All Your Market Research Reports

Covid-19 Impact on Global Drugs for Oncology Market Size, Status and Forecast 2020-2026

Drugs for Oncology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drugs for Oncology market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyzes the impact of Coronavirus COVID-19 on the Drugs for Oncology industry. The key players covered in this study Roche Celgene Novartis Bristol-Myers Squibb Johnson & Johnson Merck & Co. AstraZeneca Pfizer Amgen Eli Lilly AbbVie Takeda Astellas Ipsen Sanofi Bayer Biogen Idec Teva Otsuka Eisai Merck KGaA Gilead Sciences Market segment by Type, the product can be split into Chemotherapy Targeted Therapy Immunotherapy (Biologic Therapy) Hormonal Therapy Others Market segment by Application, split into Blood Cancer Breast Cancer Gastrointestinal Cancer Prostate Cancer Respiratory/Lung Cancer Others Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Drugs for Oncology status, future forecast, growth opportunity, key market and key players. To present the Drugs for Oncology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Drugs for Oncology are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Drugs for Oncology Revenue 1.4 Covid-19 Implications on Market by Type 1.4.1 Global Drugs for Oncology Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Chemotherapy 1.4.3 Targeted Therapy 1.4.4 Immunotherapy (Biologic Therapy) 1.4.5 Hormonal
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 533090
Category
  • Pharmaceuticals and Healthcare
Published on 12-Jun
Number of Pages 132
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(27)